Company Active LTD

Company profile

Nova Bio-Pharma Technologies Limited

UK company 06936355, incorporated on 17 June 2009.

Nova Laboratories

Nova Bio-Pharma Technologies Limited is a UK company with status Active founded in 2009 based in East Midlands.

Company number

06936355

Incorporated

17 Jun 2009

Companies House status

Active

Company identity

Founded / incorporated

17 June 2009

Company number 06936355

Verify at Companies House

Legal name

NOVA BIO-PHARMA TECHNOLOGIES LIMITED

Company type

Private Limited Company

Region

East Midlands

Registered address

MARTIN HOUSE

GLOUCESTER CRESCENT

WIGSTON

LEICESTERSHIRE

ENGLAND

LE18 4YL

Insolvency history

Corporate ownership

Updated 07 Jul 2026 09:49

2 levels 1 ultimate controller

Company Active LTD

Nova Bio-Pharma Technologies Limited

CRN 06936355

Direct controller Active LTD

Nova Bio-Pharma Holdings Limited

CRN 06600173

Ultimate controller Active LTD

Nova Nominees Limited

CRN 08785392

Company events

Reference milestones and recent Companies House filing stream events.

5 events

22 May

2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec

2026

Accounts due

Accounts Due

Next accounts due date

08 May

2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar

2025

Accounts filed

Accounts

Last accounts made up date

17 Jun

2009

Incorporated

Inception

Company registered at Companies House

Public funding

1 award

First funded

2016

Funded years

2016

Age at first award

7 years

Projects

2016 Small Business Research Initiative Lead participant

Room temperature stable MVA-GP pox vectored vaccine against CCHF

1 Sep 2016 to 31 Aug 2017

Awarded

£428,646

Total cost £428,646

The objective of the proposed programme is to achieve a room-temperature stable, ready-to-inject vaccine against Crimean-Congo haemorrhagic fever (CCHF). HydRIS (Hypodermic Re-hydration Injection System) stabilisation platform with a proven track record of successfully stabilising live viral and bacterial vectors will be assessed to stabilise MVA-GP vacci...

Product types

Small Business Research Initiative